The Ethics and Public Policy Center report on mifepristone has earned headlines on the right, but what does the data show?

In 2019, reports of a rapidly progressive dementia cluster in New Brunswick raised public and media concerns about a ...

In recent years, healthcare has witnessed a shift from traditional decision-making systems to more dynamic, real-time solutions powered by artificial intelligence and advanced analytics. Satya Manesh ...

A new study being used to call for mifepristone restrictions relies on vague and dubious definitions of drug-related ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology ...

and interpretation of trial electronic clinical outcome assessment (eCOA) data. The dashboard is designed to provide real-time insights into operations, subject behaviour, and metrics of digital ...

BioNTech will present data from the Phase 1 clinical trial LuCa-MERIT-1 (NCT05142189) for its mRNA cancer immunotherapy candidate BNT116 in combination with the anti-PD1 cemiplimab in an oral ...

BioNTech will present data from the Phase 1 clinical trial LuCa-MERIT-1 (NCT05142189) for its mRNA cancer immunotherapy candidate BNT116 in combination with the anti-PD1 cemiplimab in an oral ...

Bicara Therapeutics Inc. announced that new data from their ongoing Phase 1/1b clinical trial of ficerafusp alfa, a first-in-class bifunctional antibody, will be presented orally at the 2025 ASCO ...

--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American Society of Clinical Oncology ...